27-Year-Old Medical Device Veteran Linhua Healthcare Launches Strategic Industry Collaboration to Build a 'Flagship Alliance' Amid Volume-Based Procurement Reforms

Volume-based procurement has become a hurdle that the development of medical consumables must overcome.For enterprises, centralized volume-based procurement (VBP) is akin to a double-edged sword. On one hand, it facilitates the entry of medical consumables into hospitals; on the other, the price pressure exerted by VBP imposes greater challenges on companies’ capabilities in supply chain management and automated production, thereby intensifying industry consolidation and the survival-of-the-fittest dynamic.

Against this backdrop, Linhwa Medical, a 27-year-old veteran in the field of clinical vascular access, has officially announced the comprehensive launch of its industrial collaborations.

Leveraging Linhwa Medical’s multifaceted strengths in marketing, distribution channels, R&D, and manufacturing, the company prioritizes “transplant-style” collaborations within Suzhou or Jiangsu Province. It seeks partnerships with medical device enterprises that possess resources such as established products, registration certificates, technical leaders, and core teams. Through its subsidiary, Linhwa Holdings, the company aims to collaborate in forming a more comprehensive product portfolio and clinical solutions, jointly building an ecosystem conducive to sustainable growth.

As a leader in industrial collaboration, Suzhou Linhwa Medical Devices Co., Ltd. has cultivated deep expertise in the medical device industry for many years, establishing a prestigious brand in the field of vascular access and drug delivery. Its products are used in nearly 20,000 hospitals and healthcare institutions across China. This success is underpinned by its substantial strengths accumulated in innovative R&D, specialized marketing, and efficient automated manufacturing.

Linhwa Medical specializes in the research, development, production, and sales of vascular access products. Its main product portfolio includes intravenous catheters, implantable ports, surgical drains, and dressings. The company is committed to providing clinical healthcare professionals with products and services that offer “peace of mind for patients and ease of use for medical staff.”

IV catheters are Linhwa Medical’s “flagship business,” with more than 200 product models and specifications,Ranks Among the Top Three in Domestic Market Share, and has been widely acclaimed by clinical healthcare professionals in China. Meanwhile, Linhwa Medical is the first company in China to offer a complete portfolio of implantable venous access ports for intravenous, arterial, and intraperitoneal drug delivery. Currently,Top 3 Market Share Among Domestic Brands for Implantable Venous Access Ports。

Linhwa Medical is committed to independent research and development, holding over 100 patented technologies. The Department of Science and Technology of Jiangsu Province has designated Linhwa Medical as the “Jiangsu Provincial Engineering Technology Research Center for Vascular Drug Delivery Devices,” and the Department of Industry and Information Technology of Jiangsu Province has recognized Linhwa Medical as a Provincial Industrial Enterprise Technology Center. Meanwhile,Suzhou Linhwa Medical Devices Co., Ltd. has participated in the drafting of multiple industry standards, including YY 1282-2022 "Single-use Intravenous Indwelling Needle."。

At the marketing level, Suzhou Linhwa Medical Devices Co.,ltd.'sProfessional Academic Marketing Team of Over 400 Members, with more than two-thirds of its members coming from clinical nursing backgrounds. The team has an average professional experience of over six years and possesses extensive service expertise. Meanwhile, Linhwa MedicalEstablished a distributor channel network of over 3,000 partners across China, all equipped with highly professional and experienced senior teams, collaborating with the marketing department of Suzhou Linhwa Medical Devices Co., Ltd. to jointly provide specialized clinical services to healthcare professionals.

Currently,Linhwa Medical's marketing network covers more than 30 provinces, autonomous regions, and municipalities directly under the central government in China, with its products reaching nearly 20,000 hospitals and medical institutions., entering renowned Grade 3A hospitals in China, such as Zhongshan Hospital Affiliated to Fudan University, Wuhan Union Hospital, West China Hospital of Sichuan University, and the First Affiliated Hospital of Sun Yat-sen University. Leveraging its product advantages and comprehensive service capabilities, Suzhou Linhwa Medical Devices Co., Ltd. has maintained a high bid-winning rate in centralized procurement for intravenous catheters and implantable venous access ports.

Furthermore, clinical recognition serves as the foundation for market promotion. Suzhou Linhwa Medical Devices Co., Ltd. places particular emphasis on clinical education, collaborating with multiple benchmark hospitals across China to organize training programs and forums, thereby jointly promoting the adoption of new concepts and technologies in fields such as medical nursing and vascular intervention.

For instance, Suzhou Linhwa Medical Devices Co., Ltd. has partnered with the Chinese Nursing Association for eight consecutive years to host the "Academic Forum on High-Quality Development and Safety Management in Nursing"; collaborated with the Capacity Building and Continuing Education Center of the National Health Commission to undertake the "Peripheral Vascular Intervention" training program; and worked with the China Association of Medical Equipment to establish the Linhwa Academy Training Base, holding offline conferences in major cities across China.

Meanwhile, in 2020, Linhwa Medical launched an online live-streaming platform to provide systematic courses based on clinical practice for frontline clinical healthcare professionals across China. According to statistics, Linhwa Academy has hosted over 300 live-streamed sessions annually, with its online user base exceeding 500,000.

At the production level, since 2017, Linhwa Medical has been the first in the industry to carry out intelligent manufacturing upgrades for indwelling needles,Collaborated with top-tier domestic and international suppliers to develop multiple globally leading fully automated production lines for intravenous catheters, achieving an automation rate of up to 80%.Through continuous iterative upgrades, Linhwa Medical has established an integrated, visualized, and digitally controlled smart manufacturing production system.

In addition to Suzhou, Linhwa Medical has established production bases in Jiaxing, Xuzhou, and other locations, covering a total area of over 120,000 square meters. The company features Class 100,000 and Class A clean production workshops and has introduced globally leading intelligent manufacturing equipment, supporting multiple product lines through precise and stable process workflows. In 2021, Linhwa Medical was recognized as a Jiangsu Province “Little Giant” enterprise (manufacturing category) and received the title of Jiangsu Province Intelligent Manufacturing Demonstration Workshop in the same year.

In the face of the overarching trends of centralized procurement for medical consumables and healthcare cost containment, medical device companies may choose to go it alone by building robust supply chains and developing comprehensive product solutions, thereby ensuring revenue growth through cost reduction and volume expansion. However, for small and medium-sized enterprises (SMEs), establishing their own production lines and sales channels entails substantial upfront investment. Alternatively, they may opt to collaborate with other participants across the industry chain, leveraging each party’s core strengths to jointly cultivate an ecosystem of industrial cooperation.

From the perspective of the enterprise's own business,Linhwa Medical further enriched its product portfolio, developed supporting product solutions, actively participated in centralized procurement, and maintained a high bid-winning rate.. Meanwhile, from the perspectives of long-term corporate development and industrial advancement,Suzhou Linhwa Medical Devices Co., Ltd. aims to leverage its platform’s advantageous resources to foster the healthy development of startups and small and medium-sized enterprises (SMEs) involved in volume-based procurement products, by sharing marketing teams, distributors, hospital resources, and industry partners, thereby jointly cultivating the market and co-creating brands.。

The 26,000-square-meter incubation park, newly built in Suzhou—the headquarters location of Linhwa Medical—is set to open soon.Linhwa Holdings plans to commence construction in the Xiangcheng High-Tech Zone of Suzhou in 2024, with a total investment exceeding RMB 1.2 billion and a total gross floor area of approximately 223,000 square meters.

According to statistics from Zhongcheng Shuke, the number of valid medical device products in Jiangsu Province reached 38,661 between 2018 and 2022, accounting for 15.5% of the national total and ranking first nationwide. Medical device manufacturers in Suzhou account for one-quarter of those in Jiangsu Province, with their output value representing one-third of the provincial total.

Based on this, Linhwa Holdings will focus its efforts within Jiangsu Province.Medical device companies with resources such as products, registration certificates, and core technologies，Provide support in funding, facilities, intelligent manufacturing, and technology platforms, and enjoy cooperative rights including independent operation and equal equity with corresponding voting rights.Both parties achieve a win-win outcome through industrial cooperation that leverages their complementary strengths.

Linhwa Medical can jointly incubate new enterprises with partner companies, and can also provide assistance in any stage of the entire process, including R&D, production, and sales.The company plans to build an "aircraft carrier" platform to drive the comprehensive expansion of its products, brand, and corporate presence in the medical device market, accelerating its path to rapid growth. According to the head of industrial cooperation at Suzhou Linhwa Medical Devices Co., Ltd., the company’s short-term goal is to establish a cooperation model and forge industrial partnerships with 30 small, medium, and micro enterprises.

“Leveraging years of deep cultivation in our resources and driven by a strong sense of social responsibility, we aim to join hands with industry partners under the overarching trend of centralized procurement to achieve win-win cooperation. Our goal is to provide more comprehensive product solutions for clinical practice, enabling more healthcare professionals and patients to benefit from high-quality medical products and services.”